← Evidence library

BIB_180

Atkins MB et al. DREAMseq — Sequential Therapy in BRAF V600 Mutant Metastatic Melanoma. J Clin Oncol 2023;41(2):186–197. PMID 36166727. Establishes ICI-first then BRAF/MEK at progression as OS-superior to BRAF/MEK first then ICI. Standard sequencing for BRAF V600+ advanced. [Tasks: 18] Tier: 1 Grade: A Retrieved: 2026-05-07

Evidence grade

A

Tier

1

Cited by tasks

18

Identifiers

PMID:36166727

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_180/findings.md (research corpus). This page is a short context summary — not individualised medical advice.